Electromed, Inc. to Present at the LD Micro Invitational XVApril 03, 2025 4:00 PM EDT | Source: LD MicroNew Prague, Minnesota--(Newsfile Corp. - April 3, 2025) - Electromed, Inc. (NYSE American: ELMD) announced today that it will be participating in the 15th Annual LD Micro Invitational at the Westin Grand Central in New York on April 9th and 10th, 2025. Electromed, Inc. is scheduled to present on April 10, 2025 at 02:30 PM. Jim Cunniff, President and Chief Executive Officer, will be represent ...

Electromed, Inc. (NYSE:ELMD) Q2 2025 Earnings Conference Call February 11, 2025 5:00 PM ET Company Participants Mike Cavanaugh - IR, Westwicke Partners James Cunniff - President, CEO & Director Bradley Nagel - CFO, Treasurer & Company Secretary Conference Call Participants Brooks O’Neil - Lake Street Capital Markets Operator Good afternoon, and welcome to the Electromed Second Quarter 2025 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note, this event ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Address of principal executive offices) (Zip Code) (952) 758-9299 (Registrant's telephone number, including area code) For the transition period from to . Commission File No.: 001-34839 El ...

Exhibit 99.1 Electromed, Inc. Announces Record Financial Performance in Fiscal 2025 Second Quarter Company maintained strong momentum to deliver another quarter of record revenue and earnings, while continuing to invest in multiple strategic growth initiatives NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three and six months ended December 31, 2024 ( ...

Electromed, Inc. (NYSE:ELMD) Q1 2025 Earnings Conference Call November 12, 2024 5:00 PM ET Company Participants Mike Cavanaugh - IR, Westwicke Partners James Cunniff - President, CEO & Director Bradley Nagel - CFO, Treasurer & Company Secretary Conference Call Participants Aaron Wukmir - Lake Street Capital Markets Operator Hello, and welcome to the Electromed First Quarter 2025 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] As a reminder, this conference is ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . | --- | --- | --- | |----------------------------------------------------------------------------------------------------------------------------------- ...

Exhibit 99.1 Electromed, Inc. Announces Fiscal 2025 First Quarter Financial Results Electromed delivers eighth consecutive quarter of year-over-year revenue and profit growth, while continuing to invest in strategic growth initiatives NEW PRAGUE, Minn.--(BUSINESS WIRE) -- Electromed, Inc. ("Electromed") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2024 ("Q1 FY 2025"). Q1 FY 2025 Financial Highlights ● ...

Electromed, Inc. (NYSE:ELMD) Q4 2024 Earnings Conference Call August 27, 2024 5:00 PM ET Company Participants Mike Cavanaugh - IR, Westwicke Partners James Cunniff - President, CEO & Director Bradley Nagel - CFO, Treasurer & Company Secretary Conference Call Participants Aaron Wukmir - Lake Street Capital Markets Operator Greetings, and welcome to the Electromed Fourth Quarter 2024 Earnings Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal pr ...

Electromed, Inc. Investor Presentation August 27, 2024 NYSE American: ELMD Innovation Leader in Airway Clearance Technologies Investor Presentation | 1 Forward Looking Statements Certain statements in this press release constitute forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "potential," "should," "will," and simi ...

Revenue Growth - Homecare revenue increased by $5,558,000, or 12.6%, in fiscal 2024 compared to fiscal 2023, driven by more direct sales representatives and improved referral efficiencies [102]. - Hospital revenue rose by $455,000, or 21.9%, in fiscal 2024, attributed to increased sales representatives and higher demand for capital and disposable products [103]. - Total revenue for fiscal 2024 was $54,716,000, an increase of $6,649,000 or 13.8% from $48,067,000 in fiscal 2023 [102]. - Other revenue surged by $402,000, or 94.8%, in fiscal 2024, mainly due to increased international distributor purchases [105]. Profitability - Gross profit increased to $41,726,000, representing 76.3% of net revenues in fiscal 2024, up from $36,519,000 or 76.0% in fiscal 2023 [106]. - Net income for fiscal 2024 was $5,150,000, a 62.7% increase from $3,166,000 in fiscal 2023, driven by revenue growth and decreased professional fees [113]. Expenses - Selling, general and administrative expenses rose by $2,894,000, or 9.2%, to $34,489,000 in fiscal 2024 [106]. - SG&A payroll and compensation-related expenses increased by $2,885,000, or 14.0%, to $23,437,000 in fiscal 2024, reflecting higher compensation for sales and support personnel [107]. - Research and development expenses decreased by $260,000, or 28.4%, to $656,000 in fiscal 2024, primarily due to reduced costs associated with the SmartVest Clearway platform development [110]. Cash Flow and Investments - Cash flows from operating activities provided $9,067,000 in fiscal 2024, consisting of net income and various adjustments, despite decreases in accounts payable and accrued liabilities [114]. - Net cash used in investing activities was approximately $395,000 in fiscal 2024, including $287,000 for property and equipment expenditures [115]. - The company spent approximately $287,000 on property and equipment in fiscal 2024, significantly lower than $1,648,000 in fiscal 2023 [120]. - The company expects to finance planned equipment purchases through cash flows from operations or borrowings under the credit facility [120]. Financial Position - The company has approximately $36,496,000 in working capital, which is expected to meet liquidity needs for at least the next twelve months [117]. - The renewed credit facility provides a revolving line of credit with a maximum borrowing limit of $2,500,000, secured by a security interest in the company's assets [118]. - The company is subject to financial covenants under its credit facility, including a minimum tangible net worth of $10,125,000 [119]. Taxation - The effective tax rate for fiscal 2024 was 26.8%, up from 22.5% in fiscal 2023, influenced by state income taxes and R&D tax credits [113]. Future Plans - The company plans to expand its sales force by adding three territories and direct sales representatives to accelerate revenue growth in fiscal 2025 [91]. - The company experienced increased lead times and material costs in the supply chain during fiscal 2023, but expects a return to normal lead times in fiscal 2024 [92]. - Net interest income increased to approximately $455,000 in fiscal 2024 from $78,000 in fiscal 2023, primarily due to higher savings rates on increased cash balances [112].